Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.92 USD | +0.37% | +1.10% | +4.65% |
Mar. 15 | Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2022 | 6.94M | Sales 2023 | 8.01M | Capitalization | 5.25M |
---|---|---|---|---|---|
Net income 2022 | -21M | Net income 2023 | -5M | EV / Sales 2022 | -0.59 x |
Net cash position 2022 | 8.63M | Net cash position 2023 | 10.87M | EV / Sales 2023 | -0.7 x |
P/E ratio 2022 |
-0.2
x | P/E ratio 2023 |
-0.83
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.4% |
1 day | +0.37% | ||
1 week | +1.10% | ||
Current month | +1.08% | ||
1 month | +2.19% | ||
6 months | +16.46% | ||
Current year | +4.65% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Marchio
CEO | Chief Executive Officer | 72 | 20-11-30 |
Nancy Seretta
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Aaron Fox-Collis
AUD | Comptroller/Controller/Auditor | - | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Albert Marchio
CEO | Chief Executive Officer | 72 | 20-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 0.92 | +0.37% | 27,794 |
24-05-20 | 0.9166 | -1.81% | 9,381 |
24-05-17 | 0.9335 | 0.00% | 1,058 |
24-05-16 | 0.9335 | +3.71% | 88,297 |
24-05-15 | 0.9001 | -1.09% | 736 |
Delayed Quote OTC Markets, May 21, 2024 at 02:22 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+4.65% | 5.5M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-3.99% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- FRTX Stock